Socialiya - Entertainment. Knowledge. Community.
Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story

Despite a phase 3 miss and a difficult regulatory environment, Valneva and Pfizer remain hopeful abo...

HEALTH NEWS April 01, 2026

Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story

Despite a phase 3 miss and a difficult regulatory environment, Valneva and Pfizer remain hopeful about scoring an approval for their Lyme disease shot.

29 views 0 likes 0 comments
Share:
Despite a phase 3 miss and a difficult regulatory environment, Valneva and Pfizer remain hopeful about scoring an approval for their Lyme disease shot.

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
APNA POS
Advertisement
socialiya
Advertisement

Top Categories

Advertisement
APNA POS
Advertisement
APNA POS
Advertisement
APNA POS
Advertisement
socialiya